FIGS (FIGS) 47th Annual Raymond James Institutional Investor Conference summary
Event summary combining transcript, slides, and related documents.
47th Annual Raymond James Institutional Investor Conference summary
4 Mar, 2026Business overview and industry positioning
Focuses on premium, functional products for healthcare professionals, transforming a traditionally unbranded, commoditized industry into a branded, community-driven space.
Serves a replenishment-driven, non-seasonal, and non-cyclical market with 2.9 million active customers out of 140 million global healthcare professionals.
Positioned as the only public company in the medical apparel space, with a significant lead in product and brand recognition.
Product innovation and assortment
Proprietary FIONx and new FORMx fabrications offer technical, comfortable, and durable solutions for various healthcare environments.
Expanded product categories include under scrubs, outerwear, compression socks, footwear, and accessories, supporting a head-to-toe outfitting strategy.
Non-scrub categories, such as patented medical-grade compression socks and bags, are experiencing strong momentum and rapid sell-outs.
Core assortment is driven by 17 styles accounting for over 60% of revenue, minimizing fashion and inventory risk.
Marketing and brand campaigns
Viral campaigns like "Where Do You Wear FIGS" and partnerships with Team USA and celebrities have significantly increased brand engagement and organic traffic.
Social engagement and direct traffic have doubled or tripled year-over-year, with campaigns reaching up to 20 million views.
Latest events from FIGS
- Record 2025 growth and profitability set up a strong 2026 outlook despite new tariffs.FIGS
Q4 202527 Feb 2026 - Product innovation, global expansion, and new partnerships drive growth amid strong financials.FIGS
Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference3 Feb 2026 - All director, auditor, and executive compensation proposals were approved at the virtual meeting.FIGS
AGM 20241 Feb 2026 - Q2 revenue up 4.4%, margins down, $50M buyback, and flat-to-2% FY24 growth outlook.FIGS
Q2 20241 Feb 2026 - Data-driven innovation, advocacy, and omnichannel growth fuel expansion toward $1B sales.FIGS
TD Cowen’s 8th Annual Future of the Consumer Conference31 Jan 2026 - Strong repeat sales, innovation, and omni-channel growth drive margin recovery and expansion.FIGS
Goldman Sachs 31st Annual Global Retailing Conference22 Jan 2026 - Q3 2024 revenue fell, margins compressed, but brand, B2B, and international growth stood out.FIGS
Q3 202415 Jan 2026 - Global expansion, product innovation, and strong cash flow drive future growth.FIGS
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20252 Dec 2025 - Virtual meeting to vote on directors, auditor, and pay; strong governance and ESG focus.FIGS
Proxy Filing1 Dec 2025